Neoadjuvant chemo-nivolumab is now approved for stage IB-III lung cancer in USA, Canada, China, Australia, UK! Just out, an open access plain language manuscript on CM-816, providing the results in an accessible manner for patients & families! https://t.co/FbhJFg39j1 #LCSM
Delighted to share with you our latest paper. Here, we test the hypothesis that aging may be driven by DNA damage-induced changes to the epigenome. Mightbe due to a glitch in the software of the body that causes it to malfunction, which can be fixed with a reboot?👇 1/
My favourite study of "how often does a family with small children get a respiratory infection?" is this one, from the USA:
https://t.co/fepEzs4A6Q
Children <5y have one of 16 common respiratory viruses detected in a nasal swab 50% of the year!
Extraordinary new paper from Google on medicine & AI: When Google tuned a AI chatbot to answer common medical questions, doctors judged 92.6% of its answers right … compared to 92.9% of answers given by other doctors.
And look at the pace of improvement! https://t.co/2Tc2YTUR6E
Cancer of unknown primary (CUP) has a low prevalence but a high mortality rate.
In Annals of Oncology, the @myESMO Clinical Practice Guideline for diagnosis, treatment and follow-up of CUP:
https://t.co/QVh7RGPPhK
@JustinOlivera_1 @RajaFlores@NateEvansMD @FMilhouseMD @MichaelGalvezMD@DrZuriMurrell@doctorp23@DrGezzer How about a single tweet?
-Surgeons have two hands, use both
-Exposure is the king and queen of surgery
-Anatomy defines all
-Don’t get stuck in the waiting place
-Best tool in the OR is your own brain
-Avoid surprises
-Easy to know when to operate, harder to know when not to
Brace yourself for a plethora of perioperative immunotherapy trials for NSCLC reading out in the near future. Highlights here from Prof. @t_mitsudomi at #ESMOAsia22
How to treat patients with hydrothorax due to peritoneal dialysis? Read about our improved minimal-invasive surgical technique for permanent closure of the leakage sites: https://t.co/SGuVDKIwom @uktuebingen#thoracic#surgery#hydrothorax@UpdatesSurgery
*“It is no accident that #mutations are increasingly being questioned as the causal event in the origin of the vast majority of #cancers, as clinical data show little support f this theory when compared against the #metrics of patient #outcomes.”
https://t.co/K3bI3XwiWh
Great work by one of our members Dr. Tobias Sinnberg in finding out why people with #COVID19 experience shortness of breath even before the #lungs are damaged. Check out the study: https://t.co/ui8RfXE0O2 #SARSCoV2#coronavirus
Viele Post-COVID Patienten in Dänemark zeigen noch 9-12 Monate nach der Infektion Symptome, das zeigt diese Studie aus Nature. Viele der Beschwerden, Geschmack, Geruch, Erschöpfung etc. bei Post-COVID haben ihre Ursache im Gehirn… https://t.co/i4Uq4FLLbs
Repeat after me: good communication requires repetition.
Data: leaders are 9x more likely to be criticized for undercommunicating than overcommunicating. Those who say too little come across as unclear and uncaring.
When you're tired of your message, it's just starting to land.
A panel explored artificial intelligence and machine learning in #lungcancer during a plenary session Tuesday at #WCLC22. Read a recap in ILCN: https://t.co/iBwgeTAMIN @jebibault@georg#LCSM
This 2020 blog article by @BrianMitzman on the Career Development blog neatly summarizes many of tonight’s discussion points: “Transitioning to the OR at Your New Institution”: https://t.co/hAtP9k5kBq #CTCareers
A 33-year-old man with a history of smoking and heavy alcohol use presented to the ED in September 2019 with fever, vomiting, abdominal pain, and hemoptysis. Two days before admission, malaise, fevers, and chills had developed, with abdominal pain, nausea, and bilious vomiting.